All News #Library
Biotech
ASCO Selects Karyopharm`s Phase 3 SENTRY Trial for Myelofibrosis
21 Apr 2026 //
PR NEWSWIRE
Karyopharm Previews 2025 Revenue, Reiterates 2026 Guidance
12 Jan 2026 //
PR NEWSWIRE
Karyopharm to Report Q1 2025 Financial Results on May 12, 2025
08 May 2025 //
PR NEWSWIRE

Market Place
Sourcing Support